21 Mar 2020

A MEDICAL WORKER DESCRIBES TERRIFYING LUNG FAILURE FROM COVID-19 — EVEN IN HIS YOUNG PATIENTS

“It first struck me how different it was when I saw my first coronavirus patient go bad. I was like, Holy shit, this is not the flu. Watching this relatively young guy, gasping for air, pink frothy secretions coming out of his tube.”   By Lizzie Presser   As of

0
20 Mar 2020

U.S. MILITARY AND THE DOMESTIC CORONAVIRUS RESPONSE: KEY QUESTIONS

    By Josh Michaud and Kellie Moss The domestic response to coronavirus in the U.S. is rapidly expanding. At this point, every U.S. state and territory has declared an emergency, and President Trump has declared the pandemic to represent a national emergency. Yet there are concerns that response capabilities

0
20 Mar 2020

IVC JOINS VS IN DELAY OF CONFERENCE UNTIL JULY

    By Larry Storer The International Vein Conference scheduled for April 30-May 2 in Miami Beach, Florida, has been delayed until July, Chairman Jose I. Almeida said March 20. At the time it was either to be July 9-11 or 10-12. He hopes to have the final date nailed

0
18 Mar 2020

FDA REMOVES THE RED TAPE ON TEST DEVELOPERS MARCH 18

  Despite a decade of tightly regulating testing, the FDA is now allowing companies to proceed with their diagnostic tests for COVID-19 without first submitting them for federal review or obtaining an official emergency clearance. In the past, the FDA has warned of the personal health risks that could follow

0
14 Mar 2020

CORONAVIRUS IS UNLIKE ANYTHING IN OUR LIFETIME, AND WE HAVE TO STOP COMPARING IT TO THE FLU

   EDITOR’s NOTE: Longtime health reporter Charles Ornstein says that comparing the novel coronavirus to the flu is dangerously inaccurate. Not one public health expert he trusts has called that comparison valid. Here’s why. by Charles Ornstein   Is the United States Prepared for COVID-19? As a longtime health care

0
14 Mar 2020

ABOUT 4 IN 10 ADULTS IN THE U.S. ARE AT GREATER RISK OF DEVELOPING SERIOUS ILLNESS IF INFECTED WITH CORONAVIRUS

  Based on current understanding of risk, forty-one percent of adults ages 18 and older in the U.S. have a higher risk of developing more serious illness if they become infected with the virus that causes COVID-19, because they are older or have serious underlying health conditions, or both, according

0
11 Mar 2020

THROMBOLEX INC. BASHIR ENDOVASCULAR CATHETER FIH TRIAL RESULTS REPORTED AT AVF MEETING

    Thrombolex Inc., a medical device company focused on the design, development and manufacture of endovascular therapies for the treatment of arterial and venous thromboembolic disorders, has announced that its First-In-Human (FIH) trial confirms the early safety and feasibility of using the Bashir Endovascular Catheter for pharmaco-mechanical catheter-directed thrombolysis

0
18 Feb 2020

GEOFF MARTHA TO REPLACE OMAR ISHRAK AT MEDTRONIC APRIL 27

       Geoff Martha, who leads Medtronic’s restorative therapies group and previously oversaw the company’s spine business, will succeed Omar Ishrak as president and CEO on April 27. Ishrak ‘s nearly 10-year tenure as chairman and CEO of Medtronic will come to an end when he retires April 26.

0
12 Feb 2020

FDA OKs HYPERFINE’s BEDSIDE MRI

  The FDA has approved 510 (k) clearance for the Hyperfine Research Inc. bedside Magnetic Resonance Imaging (MRI) system, the world’s first bedside MRI. The Hyperfine system is 20 times lower cost, 35 times lower power consumption, and 10 times less weight than today’s fixed conventional MRI systems. Jonathan Rothberg,

0
12 Feb 2020

THE IMPORTANCE OF DILUENTS IN SCLEROSANTS

By Ronald Bush, MD, FACS An advantage of having access to a histology lab cannot be overstated. The ability to scientifically study various venous issues is possible. One study we have recently completed and are now submitting is comparing the critical micelle concentration (CMC) of both Sotradecol (STS) and Polidocanol

0